Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037567 | SCV000061225 | likely benign | not specified | 2017-03-26 | criteria provided, single submitter | clinical testing | p.Lys1775Glu in exon 38 of MYH9: This variant is not expected to have clinical s ignificance because it has been identified in 0.3% (75/25454) of Finnish chromos omes, including 1 homozygote, by the Genome Aggregation Database (gnomAD, http:/ /gnomad.broadinstitute.org; dbSNP rs145139708). |
Illumina Laboratory Services, |
RCV000315373 | SCV000438312 | likely benign | MYH9-related disorder | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000353893 | SCV000438313 | likely benign | Autosomal dominant nonsyndromic hearing loss 17 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Center for Pediatric Genomic Medicine, |
RCV000514769 | SCV000610237 | likely benign | not provided | 2017-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000514769 | SCV001036296 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514769 | SCV001794045 | likely benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29090586) |
Ce |
RCV000514769 | SCV002585927 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | MYH9: BS1 |
ARUP Laboratories, |
RCV000514769 | SCV003799760 | likely benign | not provided | 2023-08-25 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000514769 | SCV001798500 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000037567 | SCV001931105 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000514769 | SCV001971624 | likely benign | not provided | no assertion criteria provided | clinical testing |